Brian E. Krob

Brian Krob is a partner in Nixon Peabody's Corporate practice group. He represents corporate acquirers as well as private equity firms in their acquisitions and dispositions, with a focus on health care and technology.

What do you focus on?

Health Care Transactions

I represent for-profit and nonprofit health care clients in a wide variety of transactions. For hospitals and health systems, I advise on mergers and complex joint ventures. Physician groups turn to me for assistance with forming integrated physician networks, and representing those networks in acquisitions and sales. I also represent investors and physicians forming and investing in surgery centers, and growth equity investors in their investments and dispositions of health care portfolios.

Private Equity

Throughout my career I’ve represented private equity funds in the acquisition and disposition of their portfolio companies. While a company is being held by a private equity fund, I work with management to resolve their day-to-day legal issues, with an ultimate goal of positioning the company for disposition by the fund.

What do you see on the horizon?

Complexity in transactions will continue to rise. Almost all transactions now have international elements to them, whether representing an entity with foreign operations, a U.S. business seeking to make an acquisition abroad or a foreign investor seeking to deploy capital in the U.S. All of this is in a rising tide of uncertainty. Excellent counsel can provide practical legal strategies for managing these complexities.


  • Moderator, Virtual Private Equity Panel, BDO USA LLP, Webinar, July 29, 2020

Don't Miss It: Simpson, Latham guide week's hot deals

Law360 | May 10, 2019

Boston Corporate partner David Martland and Chicago Corporate partner Brian Krob are mentioned in this roundup of notable deals for advising Merck in its acquisition of Intermolecular.


Brian E. Krob



Phone: 312-977-4346

Fax: 844-562-6849

University of Illinois College of Law, J.D., magna cum laude, Order of the Coif

  • Associate Editor, University of Illinois Law Review

University of Kansas, B.A., with honors


Brian has been recommended in The Legal 500 United States 2021 editorial for M&A/Corporate and commercial—M&A: Middle-market (sub-$500m).He has also been recognized in previous years.

Back to top